drugset / Trial / NCT00004808
Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis
Phase 2
Completed
78 enrolled
National Center for Research Resources (NCRR)
National Institute of Allergy and Infectious Diseases (NIAID) · collabUniversity of Alabama at Birmingham · collab
Treatment
Summary
OBJECTIVES: I. Identify a preferred oral fluconazole dose regimen for patients with non-acute histoplasmosis or blastomycosis, or ulcerocutaneous or deep sporotrichosis. II. Study the safety and efficacy of fluconazole in these patients.
Timeline
- Start
- 1991-09
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluconazole | Small molecule | — | Oral |